John A Dormandy
- Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial
2005/10/01 by John Dormandy, John A Dormandy, Bernard Charbonnel +44 · 4,139 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Cardiology #Cardiovascular Function and Risk Factors #Clinical endpoint #Diabetes mellitus #Diabetes, Cardiovascular Risks, and Lipoproteins #Endocrinology #Internal medicine #Macrovascular disease #Medicine #Myocardial infarction #Peroxisome Proliferator-Activated Receptors #Pioglitazone #Placebo #Randomized controlled trial #Stroke (engine) #Surgery #Type 2 diabetes